Bibliografía
1. Scottish Intercollegiate Guidelines Network (SIGN). Management of chronic pain. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2013. p. 64. Disponible en: www.healthcare improvementscotland.or
2. Neira F, Ortega JL. Guías de Práctica Clínica en el Tratamiento del Dolor. Una herramienta en la práctica clínica. Rev Soc Esp Dolor. 2008;15(6):399-413.
3. Langley P, Muller-Schwerfe G, Nicolaou A, Liedgens H, Pergolizzi J, Varrassi G. The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization. Pain | English Journal of Medical Economics; J Med Econ. 2010;13(3):571-81. DOI: 10.3111/13696998.2010.516709.
4. Elliott A, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet. 1999;354(9186):1248-52. DOI: 10.1016/s0140-6736(99)03057-3.
5. Sjogren P, Ekholm O, Peuckmann V, Gronbaek M. Epidemiology of chronic pain in Denmark: an update. Eur J Pain. 2009;13(3):287-92. DOI: 10.1016/j.ejpain.2008.04.007.
6. Langley PC, Ruiz-Iban MA, Molina JT, De Andres J, González-Escalada Castellón. The prevalence, correlates and treatment of pain in Spain. J Med Econ. 2011;14(3):367-80. DOI: 10.3111/13696998.2011.583303.
7. Toblin RL, Mack KA, Perveen G, Paulozzi LJ. A population-based survey of chronic pain and its treatment with prescription drugs. Pain. 2011;152(6):1249-55. DOI: 10.1016/j.pain.2010.12.036.
8. Reginster JY. The prevalence and burden of arthritis. Rheumatology. 2002;41(Supp 1):3-6.
9. Ibáñez P, Pineda S, Martínez C, Tinoco J, Flor F. Prevalencia del dolor no oncológico en la consulta de Rehabilitación. Rehabilitación (Madr). 2015;49(4):224-9.
10. Vallano A, Payrulet P, Malouf J, Baños J E. Estudio multicéntrico de la evaluación del dolor en el medio hospitalario. Rev Esp Anestesio. Reanim. 2007;54(3):140-6 .
11. Bassols A, Baños JE. La epidemiología del dolor en España. Revista clínica electrónica en atención primaria. 2006;10(septiembre):1-7.
12. Casals M, Samper D. Epidemiology, prevalence and quality of lifeof non-malignant chronic pain. ITACA study. Rev Soc Esp Dolor. 2004;11(5):260-9.
13. Soares K, Sola I, Aromataris E, Tornero J, Pérez C, Margarit C, et al. Epidemiology of chronic non-malignant pain in Spain. Mayo 2010.
14. Reid KJ, Harker J, Bala MM, Truyers C, Kellen E, Bekkering GE, et al. Epidemiology of chronic non-cancer pain in Europe: Narra-tive review of prevalence, pain treatments and pain impact.Curr Med Res Opin. 2011;27(2):449-62. DOI: 10.1185/03007995.2010.545813.
15. Thomas E, Peat G, Harris L, Wilkie R, Croft PR. The prevalence of pain and pain interference in a general population of olderadults: Cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain. 2004;110(1-2):361-8. DOI: 10.1016/j.pain.2004.04.017.
16. Loza E, Lopez-Gomez JM, Abasolo L, Maese J, Carmona L, Batlle- Gualda E. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum. 2009;61(2):158-65. DOI: 10.1002/art.24214.
17. van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: A systematic review of epidemiological studies’’. Pain. 2014;155(4):654-62. DOI: 10.1016/j.pain.2013.11.013. Erratum in: Pain. 2014 Sep;155(9):1907.
18. Roerdink RL, Dietvorst M, van der Zwaard B, van der Worp H, Zwerver J. Complications of extracorporeal shockwave therapy in plantar fasciitis: Systematic revision. Int J Surg. 2017;46:133-45. DOI: 10.1016/j.ijsu.2017.08.587.
19. Lou J, Wang S, Liu S, Xing G. Effectiveness of extracorporeal shock wave therapy without local anesthesia in patients with recalcitrant plantar fasciitis: a meta-analysis of randomized controlled trials. Am J Phys Med Rehabil. 2017;96(8):529-34. DOI: 10.1097/PHM.0000000000000666.
20. Haik MN, Alburquerque-Sendín F, Moreira RF, Pires ED, Camargo PR. Effectiveness of physical therapy treatment of clearly defined subacromial pain: a systematic review of randomised controlled trials. Br J Sports Med. 2016;50(18):1124-34. DOI: 10.1136/bjsports-2015-095771.
21. Aresti N, Kassam J, Bartlett D, Kutty S. Primary care management of postoperative shoulder, hip, and knee arthroplasty BMJ. 2017;359:j4431. DOI: 10.1136/bmj.j4431.
22. Münter KH, Clemmesen CG, Foss NB, Palm H, Kristensen MT. Fatigue and pain limit independent mobility and physiotherapy after hip fracture surgery. Disabil Rehabil. 2018;40(15):1808-16. DOI: 10.1080/09638288.2017.1314556.
23. Aprato A, Casiraghi A, Pesenti G, Bechis M, Samuelly A, Galante C, et al. 48 h for femur fracture treatment: are we choosing the wrong quality index? Orthop Traumatol. 2019;20(1):11. DOI: 10.1186/s10195-019-0518-2.
24. Benhamou D, Berti M, Brodner G, De Andres J, Draisci G, Moreno‐Azcoita M, et al. Postoperative Analgesic Therapy. Observational Survey (PATHOS): a practice pattern study in 7 central/southerEuropean countries. Pain. 2008;136(1-2):134-41. DOI: 10.1016/j.pain.2007.06.028.
25. Bolibar I, Catalá E, Cadena R. El dolor en el hospital: de los estándares de prevalencia a los de calidad. Rev Esp Anestesiol Reanim. 2005;52(3):131‐40.
Artículos relacionados
Ibuprofeno intravenoso y combinaciones farmacológicas
Abad Gurumeta A, Bergese SD, Zuleta-Alarcón A, Fiorda- Díaz J, Martínez Ruiz A, Casans Francés R, Ripollés Melchor J y Calvo Vecino JM. Ibuprofeno intravenoso y combinaciones farmacológicas. Rev Soc Esp Dolor 2016;23(Supl. I):31-34.